nodes	percent_of_prediction	percent_of_DWPC	metapath
Mercaptopurine—PPAT—Fluorouracil—breast cancer	0.126	0.203	CbGbCtD
Mercaptopurine—SLC29A2—Gemcitabine—breast cancer	0.0982	0.158	CbGbCtD
Mercaptopurine—SLC28A3—Gemcitabine—breast cancer	0.0849	0.136	CbGbCtD
Mercaptopurine—AOX1—Raloxifene—breast cancer	0.0717	0.115	CbGbCtD
Mercaptopurine—SLC29A1—Gemcitabine—breast cancer	0.0564	0.0906	CbGbCtD
Mercaptopurine—SLC29A1—Fluorouracil—breast cancer	0.0483	0.0775	CbGbCtD
Mercaptopurine—ABCC5—Fluorouracil—breast cancer	0.0369	0.0592	CbGbCtD
Mercaptopurine—XDH—Carboplatin—breast cancer	0.03	0.0481	CbGbCtD
Mercaptopurine—AOX1—Methotrexate—breast cancer	0.0192	0.0309	CbGbCtD
Mercaptopurine—ABCC4—Fluorouracil—breast cancer	0.0177	0.0284	CbGbCtD
Mercaptopurine—XDH—Doxorubicin—breast cancer	0.0172	0.0276	CbGbCtD
Mercaptopurine—ABCC4—Methotrexate—breast cancer	0.00977	0.0157	CbGbCtD
Mercaptopurine—SLC22A8—Methotrexate—breast cancer	0.0061	0.0098	CbGbCtD
Mercaptopurine—Adenine—APRT—breast cancer	0.004	1	CrCbGaD
Mercaptopurine—SLC28A3—nipple—breast cancer	0.00244	0.0363	CbGeAlD
Mercaptopurine—PPAT—nipple—breast cancer	0.00215	0.032	CbGeAlD
Mercaptopurine—HPRT1—mammary gland—breast cancer	0.00199	0.0297	CbGeAlD
Mercaptopurine—HPRT1—nipple—breast cancer	0.00165	0.0245	CbGeAlD
Mercaptopurine—ABCC5—mammary gland—breast cancer	0.00146	0.0217	CbGeAlD
Mercaptopurine—TPMT—nipple—breast cancer	0.00139	0.0207	CbGeAlD
Mercaptopurine—HPRT1—embryo—breast cancer	0.00136	0.0202	CbGeAlD
Mercaptopurine—SLC29A1—mammary gland—breast cancer	0.00134	0.0199	CbGeAlD
Mercaptopurine—SLC28A3—adipose tissue—breast cancer	0.00133	0.0198	CbGeAlD
Mercaptopurine—PPAT—endometrium—breast cancer	0.0013	0.0193	CbGeAlD
Mercaptopurine—SLC29A2—adipose tissue—breast cancer	0.00122	0.0181	CbGeAlD
Mercaptopurine—PPAT—pituitary gland—breast cancer	0.00117	0.0175	CbGeAlD
Mercaptopurine—PPAT—adipose tissue—breast cancer	0.00117	0.0174	CbGeAlD
Mercaptopurine—SLC28A3—bone marrow—breast cancer	0.00115	0.0172	CbGeAlD
Mercaptopurine—SLC29A2—female reproductive system—breast cancer	0.00112	0.0166	CbGeAlD
Mercaptopurine—SLC28A3—female gonad—breast cancer	0.00111	0.0165	CbGeAlD
Mercaptopurine—SLC29A1—nipple—breast cancer	0.00111	0.0165	CbGeAlD
Mercaptopurine—SLC29A2—adrenal gland—breast cancer	0.00109	0.0162	CbGeAlD
Mercaptopurine—PPAT—female reproductive system—breast cancer	0.00108	0.016	CbGeAlD
Mercaptopurine—HPRT1—skin of body—breast cancer	0.00106	0.0157	CbGeAlD
Mercaptopurine—PPAT—adrenal gland—breast cancer	0.00105	0.0156	CbGeAlD
Mercaptopurine—AOX1—nipple—breast cancer	0.00104	0.0154	CbGeAlD
Mercaptopurine—PPAT—bone marrow—breast cancer	0.00102	0.0151	CbGeAlD
Mercaptopurine—HPRT1—endometrium—breast cancer	0.000996	0.0148	CbGeAlD
Mercaptopurine—XDH—endometrium—breast cancer	0.000984	0.0146	CbGeAlD
Mercaptopurine—PPAT—female gonad—breast cancer	0.000978	0.0146	CbGeAlD
Mercaptopurine—SLC29A2—endocrine gland—breast cancer	0.000945	0.0141	CbGeAlD
Mercaptopurine—HPRT1—uterus—breast cancer	0.000918	0.0137	CbGeAlD
Mercaptopurine—PPAT—endocrine gland—breast cancer	0.00091	0.0135	CbGeAlD
Mercaptopurine—HPRT1—pituitary gland—breast cancer	0.000901	0.0134	CbGeAlD
Mercaptopurine—HPRT1—adipose tissue—breast cancer	0.000898	0.0134	CbGeAlD
Mercaptopurine—TPMT—endometrium—breast cancer	0.00084	0.0125	CbGeAlD
Mercaptopurine—HPRT1—female reproductive system—breast cancer	0.000825	0.0123	CbGeAlD
Mercaptopurine—XDH—female reproductive system—breast cancer	0.000815	0.0121	CbGeAlD
Mercaptopurine—HPRT1—adrenal gland—breast cancer	0.000805	0.012	CbGeAlD
Mercaptopurine—HPRT1—bone marrow—breast cancer	0.000779	0.0116	CbGeAlD
Mercaptopurine—TPMT—pituitary gland—breast cancer	0.00076	0.0113	CbGeAlD
Mercaptopurine—TPMT—adipose tissue—breast cancer	0.000757	0.0113	CbGeAlD
Mercaptopurine—HPRT1—female gonad—breast cancer	0.000751	0.0112	CbGeAlD
Mercaptopurine—HPRT1—endocrine gland—breast cancer	0.000698	0.0104	CbGeAlD
Mercaptopurine—XDH—endocrine gland—breast cancer	0.00069	0.0103	CbGeAlD
Mercaptopurine—TPMT—adrenal gland—breast cancer	0.000679	0.0101	CbGeAlD
Mercaptopurine—SLC29A1—endometrium—breast cancer	0.000669	0.00995	CbGeAlD
Mercaptopurine—ABCC5—pituitary gland—breast cancer	0.000659	0.0098	CbGeAlD
Mercaptopurine—TPMT—bone marrow—breast cancer	0.000657	0.00977	CbGeAlD
Mercaptopurine—ABCC5—adipose tissue—breast cancer	0.000656	0.00976	CbGeAlD
Mercaptopurine—SLC29A2—lymph node—breast cancer	0.000654	0.00972	CbGeAlD
Mercaptopurine—TPMT—female gonad—breast cancer	0.000633	0.00942	CbGeAlD
Mercaptopurine—PPAT—lymph node—breast cancer	0.000629	0.00936	CbGeAlD
Mercaptopurine—AOX1—endometrium—breast cancer	0.000625	0.0093	CbGeAlD
Mercaptopurine—SLC29A1—uterus—breast cancer	0.000616	0.00916	CbGeAlD
Mercaptopurine—SLC29A1—pituitary gland—breast cancer	0.000605	0.009	CbGeAlD
Mercaptopurine—SLC29A1—adipose tissue—breast cancer	0.000603	0.00896	CbGeAlD
Mercaptopurine—TPMT—endocrine gland—breast cancer	0.000589	0.00876	CbGeAlD
Mercaptopurine—ABCC5—adrenal gland—breast cancer	0.000589	0.00876	CbGeAlD
Mercaptopurine—AOX1—uterus—breast cancer	0.000576	0.00857	CbGeAlD
Mercaptopurine—ABCC5—bone marrow—breast cancer	0.00057	0.00847	CbGeAlD
Mercaptopurine—AOX1—pituitary gland—breast cancer	0.000566	0.00842	CbGeAlD
Mercaptopurine—AOX1—adipose tissue—breast cancer	0.000563	0.00838	CbGeAlD
Mercaptopurine—SLC29A1—female reproductive system—breast cancer	0.000554	0.00824	CbGeAlD
Mercaptopurine—ABCC5—female gonad—breast cancer	0.000549	0.00816	CbGeAlD
Mercaptopurine—SLC29A1—adrenal gland—breast cancer	0.00054	0.00804	CbGeAlD
Mercaptopurine—SLC29A1—bone marrow—breast cancer	0.000523	0.00778	CbGeAlD
Mercaptopurine—AOX1—female reproductive system—breast cancer	0.000518	0.0077	CbGeAlD
Mercaptopurine—AOX1—adrenal gland—breast cancer	0.000505	0.00752	CbGeAlD
Mercaptopurine—SLC29A1—female gonad—breast cancer	0.000504	0.0075	CbGeAlD
Mercaptopurine—HPRT1—lymph node—breast cancer	0.000483	0.00718	CbGeAlD
Mercaptopurine—AOX1—female gonad—breast cancer	0.000471	0.00701	CbGeAlD
Mercaptopurine—SLC29A1—endocrine gland—breast cancer	0.000469	0.00697	CbGeAlD
Mercaptopurine—ABCC4—uterus—breast cancer	0.000465	0.00692	CbGeAlD
Mercaptopurine—ABCC4—adipose tissue—breast cancer	0.000455	0.00677	CbGeAlD
Mercaptopurine—AOX1—endocrine gland—breast cancer	0.000438	0.00652	CbGeAlD
Mercaptopurine—ABCC4—female reproductive system—breast cancer	0.000418	0.00622	CbGeAlD
Mercaptopurine—ABCC4—adrenal gland—breast cancer	0.000408	0.00607	CbGeAlD
Mercaptopurine—TPMT—lymph node—breast cancer	0.000407	0.00605	CbGeAlD
Mercaptopurine—ABCC4—bone marrow—breast cancer	0.000395	0.00587	CbGeAlD
Mercaptopurine—ABCC4—female gonad—breast cancer	0.00038	0.00566	CbGeAlD
Mercaptopurine—ABCC4—endocrine gland—breast cancer	0.000354	0.00526	CbGeAlD
Mercaptopurine—ABCC5—lymph node—breast cancer	0.000353	0.00525	CbGeAlD
Mercaptopurine—SLC29A1—lymph node—breast cancer	0.000324	0.00482	CbGeAlD
Mercaptopurine—AOX1—lymph node—breast cancer	0.000303	0.00451	CbGeAlD
Mercaptopurine—ABCC4—lymph node—breast cancer	0.000245	0.00364	CbGeAlD
Mercaptopurine—Leukopenia—Irinotecan—breast cancer	0.000116	0.000706	CcSEcCtD
Mercaptopurine—Mouth ulceration—Doxorubicin—breast cancer	0.000116	0.000704	CcSEcCtD
Mercaptopurine—Neoplasm—Doxorubicin—breast cancer	0.000116	0.000704	CcSEcCtD
Mercaptopurine—Diarrhoea—Chlorambucil—breast cancer	0.000115	0.000702	CcSEcCtD
Mercaptopurine—Anaemia—Fluorouracil—breast cancer	0.000115	0.000698	CcSEcCtD
Mercaptopurine—Hypersensitivity—Vinblastine—breast cancer	0.000114	0.000692	CcSEcCtD
Mercaptopurine—Body temperature increased—Goserelin—breast cancer	0.000113	0.000689	CcSEcCtD
Mercaptopurine—Leukopenia—Gemcitabine—breast cancer	0.000113	0.000688	CcSEcCtD
Mercaptopurine—Stomatitis—Docetaxel—breast cancer	0.000112	0.00068	CcSEcCtD
Mercaptopurine—Musculoskeletal discomfort—Thiotepa—breast cancer	0.000112	0.000679	CcSEcCtD
Mercaptopurine—Decreased appetite—Vinorelbine—breast cancer	0.000112	0.000679	CcSEcCtD
Mercaptopurine—Leukopenia—Fluorouracil—breast cancer	0.000111	0.000676	CcSEcCtD
Mercaptopurine—Sepsis—Doxorubicin—breast cancer	0.000111	0.000676	CcSEcCtD
Mercaptopurine—Gastrointestinal disorder—Vinorelbine—breast cancer	0.000111	0.000674	CcSEcCtD
Mercaptopurine—Hypersensitivity—Tamoxifen—breast cancer	0.000111	0.000672	CcSEcCtD
Mercaptopurine—Arthralgia—Mitoxantrone—breast cancer	0.000111	0.000672	CcSEcCtD
Mercaptopurine—Immune system disorder—Paclitaxel—breast cancer	0.00011	0.000668	CcSEcCtD
Mercaptopurine—Hepatobiliary disease—Docetaxel—breast cancer	0.000109	0.00066	CcSEcCtD
Mercaptopurine—Stomatitis—Capecitabine—breast cancer	0.000108	0.000659	CcSEcCtD
Mercaptopurine—Hypersensitivity—Melphalan—breast cancer	0.000108	0.000658	CcSEcCtD
Mercaptopurine—Arthralgia—Gemcitabine—breast cancer	0.000108	0.000654	CcSEcCtD
Mercaptopurine—Alopecia—Paclitaxel—breast cancer	0.000108	0.000653	CcSEcCtD
Mercaptopurine—Vomiting—Chlorambucil—breast cancer	0.000107	0.000652	CcSEcCtD
Mercaptopurine—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—breast cancer	0.000107	0.00065	CcSEcCtD
Mercaptopurine—Decreased appetite—Thiotepa—breast cancer	0.000107	0.000648	CcSEcCtD
Mercaptopurine—Oedema—Mitoxantrone—breast cancer	0.000106	0.000644	CcSEcCtD
Mercaptopurine—Oedema—Irinotecan—breast cancer	0.000106	0.000644	CcSEcCtD
Mercaptopurine—Gastrointestinal disorder—Thiotepa—breast cancer	0.000106	0.000644	CcSEcCtD
Mercaptopurine—Malnutrition—Paclitaxel—breast cancer	0.000106	0.000644	CcSEcCtD
Mercaptopurine—Diarrhoea—Vinblastine—breast cancer	0.000106	0.000643	CcSEcCtD
Mercaptopurine—Hypersensitivity—Goserelin—breast cancer	0.000106	0.000642	CcSEcCtD
Mercaptopurine—Hepatobiliary disease—Capecitabine—breast cancer	0.000105	0.000639	CcSEcCtD
Mercaptopurine—Thrombocytopenia—Mitoxantrone—breast cancer	0.000104	0.000631	CcSEcCtD
Mercaptopurine—Thrombocytopenia—Irinotecan—breast cancer	0.000104	0.000631	CcSEcCtD
Mercaptopurine—Oedema—Gemcitabine—breast cancer	0.000103	0.000627	CcSEcCtD
Mercaptopurine—Skin disorder—Mitoxantrone—breast cancer	0.000103	0.000626	CcSEcCtD
Mercaptopurine—Diarrhoea—Tamoxifen—breast cancer	0.000103	0.000625	CcSEcCtD
Mercaptopurine—Body temperature increased—Vinorelbine—breast cancer	0.000102	0.000617	CcSEcCtD
Mercaptopurine—Oedema—Fluorouracil—breast cancer	0.000102	0.000617	CcSEcCtD
Mercaptopurine—Thrombocytopenia—Gemcitabine—breast cancer	0.000101	0.000614	CcSEcCtD
Mercaptopurine—Anorexia—Irinotecan—breast cancer	0.000101	0.000614	CcSEcCtD
Mercaptopurine—Anorexia—Mitoxantrone—breast cancer	0.000101	0.000614	CcSEcCtD
Mercaptopurine—Diarrhoea—Melphalan—breast cancer	0.000101	0.000612	CcSEcCtD
Mercaptopurine—Skin disorder—Gemcitabine—breast cancer	0.0001	0.000609	CcSEcCtD
Mercaptopurine—Nausea—Chlorambucil—breast cancer	0.0001	0.000609	CcSEcCtD
Mercaptopurine—Thrombocytopenia—Fluorouracil—breast cancer	9.94e-05	0.000604	CcSEcCtD
Mercaptopurine—Anorexia—Gemcitabine—breast cancer	9.84e-05	0.000598	CcSEcCtD
Mercaptopurine—Vomiting—Vinblastine—breast cancer	9.83e-05	0.000597	CcSEcCtD
Mercaptopurine—Diarrhoea—Goserelin—breast cancer	9.82e-05	0.000596	CcSEcCtD
Mercaptopurine—Anaemia—Paclitaxel—breast cancer	9.79e-05	0.000595	CcSEcCtD
Mercaptopurine—Breast disorder—Methotrexate—breast cancer	9.71e-05	0.00059	CcSEcCtD
Mercaptopurine—Body temperature increased—Thiotepa—breast cancer	9.7e-05	0.000589	CcSEcCtD
Mercaptopurine—Anorexia—Fluorouracil—breast cancer	9.68e-05	0.000588	CcSEcCtD
Mercaptopurine—Musculoskeletal discomfort—Mitoxantrone—breast cancer	9.66e-05	0.000587	CcSEcCtD
Mercaptopurine—Vomiting—Tamoxifen—breast cancer	9.55e-05	0.00058	CcSEcCtD
Mercaptopurine—Leukopenia—Paclitaxel—breast cancer	9.48e-05	0.000576	CcSEcCtD
Mercaptopurine—Rash—Tamoxifen—breast cancer	9.47e-05	0.000576	CcSEcCtD
Mercaptopurine—Hypersensitivity—Vinorelbine—breast cancer	9.47e-05	0.000575	CcSEcCtD
Mercaptopurine—Dermatitis—Tamoxifen—breast cancer	9.46e-05	0.000575	CcSEcCtD
Mercaptopurine—Musculoskeletal discomfort—Gemcitabine—breast cancer	9.41e-05	0.000572	CcSEcCtD
Mercaptopurine—Vomiting—Melphalan—breast cancer	9.35e-05	0.000568	CcSEcCtD
Mercaptopurine—Immune system disorder—Docetaxel—breast cancer	9.32e-05	0.000566	CcSEcCtD
Mercaptopurine—Rash—Melphalan—breast cancer	9.28e-05	0.000564	CcSEcCtD
Mercaptopurine—Dermatitis—Melphalan—breast cancer	9.27e-05	0.000563	CcSEcCtD
Mercaptopurine—Musculoskeletal discomfort—Fluorouracil—breast cancer	9.25e-05	0.000562	CcSEcCtD
Mercaptopurine—Decreased appetite—Irinotecan—breast cancer	9.21e-05	0.00056	CcSEcCtD
Mercaptopurine—Decreased appetite—Mitoxantrone—breast cancer	9.21e-05	0.00056	CcSEcCtD
Mercaptopurine—Nausea—Vinblastine—breast cancer	9.19e-05	0.000558	CcSEcCtD
Mercaptopurine—Gastrointestinal disorder—Irinotecan—breast cancer	9.15e-05	0.000556	CcSEcCtD
Mercaptopurine—Vomiting—Goserelin—breast cancer	9.12e-05	0.000554	CcSEcCtD
Mercaptopurine—Alopecia—Docetaxel—breast cancer	9.11e-05	0.000554	CcSEcCtD
Mercaptopurine—Pancreatitis—Methotrexate—breast cancer	9.11e-05	0.000553	CcSEcCtD
Mercaptopurine—Breast disorder—Epirubicin—breast cancer	9.09e-05	0.000552	CcSEcCtD
Mercaptopurine—Rash—Goserelin—breast cancer	9.05e-05	0.00055	CcSEcCtD
Mercaptopurine—Hypersensitivity—Thiotepa—breast cancer	9.04e-05	0.000549	CcSEcCtD
Mercaptopurine—Dermatitis—Goserelin—breast cancer	9.04e-05	0.000549	CcSEcCtD
Mercaptopurine—Immune system disorder—Capecitabine—breast cancer	9.02e-05	0.000548	CcSEcCtD
Mercaptopurine—Arthralgia—Paclitaxel—breast cancer	9.02e-05	0.000548	CcSEcCtD
Mercaptopurine—Malnutrition—Docetaxel—breast cancer	8.98e-05	0.000545	CcSEcCtD
Mercaptopurine—Decreased appetite—Gemcitabine—breast cancer	8.98e-05	0.000545	CcSEcCtD
Mercaptopurine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—breast cancer	8.96e-05	0.000544	CcSEcCtD
Mercaptopurine—Nausea—Tamoxifen—breast cancer	8.92e-05	0.000542	CcSEcCtD
Mercaptopurine—Gastrointestinal disorder—Gemcitabine—breast cancer	8.91e-05	0.000542	CcSEcCtD
Mercaptopurine—Decreased appetite—Fluorouracil—breast cancer	8.83e-05	0.000536	CcSEcCtD
Mercaptopurine—Alopecia—Capecitabine—breast cancer	8.82e-05	0.000536	CcSEcCtD
Mercaptopurine—Pancytopenia—Methotrexate—breast cancer	8.82e-05	0.000536	CcSEcCtD
Mercaptopurine—Diarrhoea—Vinorelbine—breast cancer	8.79e-05	0.000534	CcSEcCtD
Mercaptopurine—Gastrointestinal disorder—Fluorouracil—breast cancer	8.76e-05	0.000532	CcSEcCtD
Mercaptopurine—Nausea—Melphalan—breast cancer	8.74e-05	0.000531	CcSEcCtD
Mercaptopurine—Malnutrition—Capecitabine—breast cancer	8.69e-05	0.000528	CcSEcCtD
Mercaptopurine—Oedema—Paclitaxel—breast cancer	8.64e-05	0.000525	CcSEcCtD
Mercaptopurine—Nausea—Goserelin—breast cancer	8.52e-05	0.000518	CcSEcCtD
Mercaptopurine—Pancreatitis—Epirubicin—breast cancer	8.52e-05	0.000518	CcSEcCtD
Mercaptopurine—Thrombocytopenia—Paclitaxel—breast cancer	8.46e-05	0.000514	CcSEcCtD
Mercaptopurine—Breast disorder—Doxorubicin—breast cancer	8.41e-05	0.000511	CcSEcCtD
Mercaptopurine—Diarrhoea—Thiotepa—breast cancer	8.4e-05	0.00051	CcSEcCtD
Mercaptopurine—Skin disorder—Paclitaxel—breast cancer	8.4e-05	0.00051	CcSEcCtD
Mercaptopurine—Body temperature increased—Irinotecan—breast cancer	8.38e-05	0.000509	CcSEcCtD
Mercaptopurine—Body temperature increased—Mitoxantrone—breast cancer	8.38e-05	0.000509	CcSEcCtD
Mercaptopurine—Anaemia—Docetaxel—breast cancer	8.3e-05	0.000504	CcSEcCtD
Mercaptopurine—Pancytopenia—Epirubicin—breast cancer	8.25e-05	0.000501	CcSEcCtD
Mercaptopurine—Anorexia—Paclitaxel—breast cancer	8.24e-05	0.000501	CcSEcCtD
Mercaptopurine—Vomiting—Vinorelbine—breast cancer	8.17e-05	0.000496	CcSEcCtD
Mercaptopurine—Body temperature increased—Gemcitabine—breast cancer	8.16e-05	0.000496	CcSEcCtD
Mercaptopurine—Rash—Vinorelbine—breast cancer	8.1e-05	0.000492	CcSEcCtD
Mercaptopurine—Dermatitis—Vinorelbine—breast cancer	8.1e-05	0.000492	CcSEcCtD
Mercaptopurine—Stomatitis—Methotrexate—breast cancer	8.07e-05	0.00049	CcSEcCtD
Mercaptopurine—Leukopenia—Docetaxel—breast cancer	8.04e-05	0.000488	CcSEcCtD
Mercaptopurine—Anaemia—Capecitabine—breast cancer	8.03e-05	0.000488	CcSEcCtD
Mercaptopurine—Body temperature increased—Fluorouracil—breast cancer	8.03e-05	0.000488	CcSEcCtD
Mercaptopurine—Pancreatitis—Doxorubicin—breast cancer	7.88e-05	0.000479	CcSEcCtD
Mercaptopurine—Musculoskeletal discomfort—Paclitaxel—breast cancer	7.88e-05	0.000478	CcSEcCtD
Mercaptopurine—Hepatobiliary disease—Methotrexate—breast cancer	7.83e-05	0.000476	CcSEcCtD
Mercaptopurine—Hypersensitivity—Irinotecan—breast cancer	7.81e-05	0.000474	CcSEcCtD
Mercaptopurine—Hypersensitivity—Mitoxantrone—breast cancer	7.81e-05	0.000474	CcSEcCtD
Mercaptopurine—Vomiting—Thiotepa—breast cancer	7.8e-05	0.000474	CcSEcCtD
Mercaptopurine—Leukopenia—Capecitabine—breast cancer	7.78e-05	0.000473	CcSEcCtD
Mercaptopurine—Rash—Thiotepa—breast cancer	7.74e-05	0.00047	CcSEcCtD
Mercaptopurine—Dermatitis—Thiotepa—breast cancer	7.73e-05	0.00047	CcSEcCtD
Mercaptopurine—Arthralgia—Docetaxel—breast cancer	7.64e-05	0.000464	CcSEcCtD
Mercaptopurine—Pancytopenia—Doxorubicin—breast cancer	7.64e-05	0.000464	CcSEcCtD
Mercaptopurine—Nausea—Vinorelbine—breast cancer	7.63e-05	0.000464	CcSEcCtD
Mercaptopurine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	7.59e-05	0.000461	CcSEcCtD
Mercaptopurine—Stomatitis—Epirubicin—breast cancer	7.55e-05	0.000459	CcSEcCtD
Mercaptopurine—Decreased appetite—Paclitaxel—breast cancer	7.51e-05	0.000457	CcSEcCtD
Mercaptopurine—Hypersensitivity—Fluorouracil—breast cancer	7.48e-05	0.000454	CcSEcCtD
Mercaptopurine—Gastrointestinal disorder—Paclitaxel—breast cancer	7.46e-05	0.000453	CcSEcCtD
Mercaptopurine—Arthralgia—Capecitabine—breast cancer	7.4e-05	0.00045	CcSEcCtD
Mercaptopurine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	7.35e-05	0.000446	CcSEcCtD
Mercaptopurine—Hepatobiliary disease—Epirubicin—breast cancer	7.33e-05	0.000445	CcSEcCtD
Mercaptopurine—Oedema—Docetaxel—breast cancer	7.33e-05	0.000445	CcSEcCtD
Mercaptopurine—Nausea—Thiotepa—breast cancer	7.29e-05	0.000443	CcSEcCtD
Mercaptopurine—Diarrhoea—Mitoxantrone—breast cancer	7.25e-05	0.000441	CcSEcCtD
Mercaptopurine—Diarrhoea—Irinotecan—breast cancer	7.25e-05	0.000441	CcSEcCtD
Mercaptopurine—Thrombocytopenia—Docetaxel—breast cancer	7.17e-05	0.000436	CcSEcCtD
Mercaptopurine—Skin disorder—Docetaxel—breast cancer	7.12e-05	0.000432	CcSEcCtD
Mercaptopurine—Oedema—Capecitabine—breast cancer	7.09e-05	0.000431	CcSEcCtD
Mercaptopurine—Diarrhoea—Gemcitabine—breast cancer	7.06e-05	0.000429	CcSEcCtD
Mercaptopurine—Stomatitis—Doxorubicin—breast cancer	6.99e-05	0.000425	CcSEcCtD
Mercaptopurine—Anorexia—Docetaxel—breast cancer	6.98e-05	0.000424	CcSEcCtD
Mercaptopurine—Diarrhoea—Fluorouracil—breast cancer	6.95e-05	0.000422	CcSEcCtD
Mercaptopurine—Thrombocytopenia—Capecitabine—breast cancer	6.95e-05	0.000422	CcSEcCtD
Mercaptopurine—Skin disorder—Capecitabine—breast cancer	6.89e-05	0.000419	CcSEcCtD
Mercaptopurine—Body temperature increased—Paclitaxel—breast cancer	6.83e-05	0.000415	CcSEcCtD
Mercaptopurine—Hepatobiliary disease—Doxorubicin—breast cancer	6.78e-05	0.000412	CcSEcCtD
Mercaptopurine—Anorexia—Capecitabine—breast cancer	6.76e-05	0.000411	CcSEcCtD
Mercaptopurine—Vomiting—Mitoxantrone—breast cancer	6.74e-05	0.000409	CcSEcCtD
Mercaptopurine—Vomiting—Irinotecan—breast cancer	6.74e-05	0.000409	CcSEcCtD
Mercaptopurine—Immune system disorder—Methotrexate—breast cancer	6.71e-05	0.000408	CcSEcCtD
Mercaptopurine—Rash—Mitoxantrone—breast cancer	6.68e-05	0.000406	CcSEcCtD
Mercaptopurine—Rash—Irinotecan—breast cancer	6.68e-05	0.000406	CcSEcCtD
Mercaptopurine—Dermatitis—Irinotecan—breast cancer	6.68e-05	0.000406	CcSEcCtD
Mercaptopurine—Dermatitis—Mitoxantrone—breast cancer	6.68e-05	0.000406	CcSEcCtD
Mercaptopurine—Musculoskeletal discomfort—Docetaxel—breast cancer	6.68e-05	0.000406	CcSEcCtD
Mercaptopurine—Alopecia—Methotrexate—breast cancer	6.57e-05	0.000399	CcSEcCtD
Mercaptopurine—Vomiting—Gemcitabine—breast cancer	6.57e-05	0.000399	CcSEcCtD
Mercaptopurine—Rash—Gemcitabine—breast cancer	6.51e-05	0.000396	CcSEcCtD
Mercaptopurine—Dermatitis—Gemcitabine—breast cancer	6.5e-05	0.000395	CcSEcCtD
Mercaptopurine—Malnutrition—Methotrexate—breast cancer	6.47e-05	0.000393	CcSEcCtD
Mercaptopurine—Musculoskeletal discomfort—Capecitabine—breast cancer	6.46e-05	0.000393	CcSEcCtD
Mercaptopurine—Vomiting—Fluorouracil—breast cancer	6.45e-05	0.000392	CcSEcCtD
Mercaptopurine—Rash—Fluorouracil—breast cancer	6.4e-05	0.000389	CcSEcCtD
Mercaptopurine—Dermatitis—Fluorouracil—breast cancer	6.4e-05	0.000389	CcSEcCtD
Mercaptopurine—Decreased appetite—Docetaxel—breast cancer	6.37e-05	0.000387	CcSEcCtD
Mercaptopurine—Hypersensitivity—Paclitaxel—breast cancer	6.37e-05	0.000387	CcSEcCtD
Mercaptopurine—Gastrointestinal disorder—Docetaxel—breast cancer	6.33e-05	0.000384	CcSEcCtD
Mercaptopurine—Nausea—Irinotecan—breast cancer	6.3e-05	0.000383	CcSEcCtD
Mercaptopurine—Nausea—Mitoxantrone—breast cancer	6.3e-05	0.000383	CcSEcCtD
Mercaptopurine—Immune system disorder—Epirubicin—breast cancer	6.28e-05	0.000382	CcSEcCtD
Mercaptopurine—Decreased appetite—Capecitabine—breast cancer	6.17e-05	0.000375	CcSEcCtD
Mercaptopurine—Alopecia—Epirubicin—breast cancer	6.15e-05	0.000373	CcSEcCtD
Mercaptopurine—Nausea—Gemcitabine—breast cancer	6.13e-05	0.000373	CcSEcCtD
Mercaptopurine—Gastrointestinal disorder—Capecitabine—breast cancer	6.12e-05	0.000372	CcSEcCtD
Mercaptopurine—Malnutrition—Epirubicin—breast cancer	6.06e-05	0.000368	CcSEcCtD
Mercaptopurine—Nausea—Fluorouracil—breast cancer	6.03e-05	0.000366	CcSEcCtD
Mercaptopurine—Anaemia—Methotrexate—breast cancer	5.98e-05	0.000363	CcSEcCtD
Mercaptopurine—Diarrhoea—Paclitaxel—breast cancer	5.91e-05	0.000359	CcSEcCtD
Mercaptopurine—Immune system disorder—Doxorubicin—breast cancer	5.81e-05	0.000353	CcSEcCtD
Mercaptopurine—Body temperature increased—Docetaxel—breast cancer	5.79e-05	0.000352	CcSEcCtD
Mercaptopurine—Leukopenia—Methotrexate—breast cancer	5.79e-05	0.000352	CcSEcCtD
Mercaptopurine—Alopecia—Doxorubicin—breast cancer	5.69e-05	0.000346	CcSEcCtD
Mercaptopurine—Body temperature increased—Capecitabine—breast cancer	5.61e-05	0.000341	CcSEcCtD
Mercaptopurine—Malnutrition—Doxorubicin—breast cancer	5.6e-05	0.00034	CcSEcCtD
Mercaptopurine—Anaemia—Epirubicin—breast cancer	5.6e-05	0.00034	CcSEcCtD
Mercaptopurine—Arthralgia—Methotrexate—breast cancer	5.51e-05	0.000335	CcSEcCtD
Mercaptopurine—Vomiting—Paclitaxel—breast cancer	5.5e-05	0.000334	CcSEcCtD
Mercaptopurine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	5.47e-05	0.000332	CcSEcCtD
Mercaptopurine—Rash—Paclitaxel—breast cancer	5.45e-05	0.000331	CcSEcCtD
Mercaptopurine—Dermatitis—Paclitaxel—breast cancer	5.45e-05	0.000331	CcSEcCtD
Mercaptopurine—Leukopenia—Epirubicin—breast cancer	5.42e-05	0.000329	CcSEcCtD
Mercaptopurine—Hypersensitivity—Docetaxel—breast cancer	5.4e-05	0.000328	CcSEcCtD
Mercaptopurine—Hypersensitivity—Capecitabine—breast cancer	5.23e-05	0.000318	CcSEcCtD
Mercaptopurine—Anaemia—Doxorubicin—breast cancer	5.18e-05	0.000315	CcSEcCtD
Mercaptopurine—Thrombocytopenia—Methotrexate—breast cancer	5.17e-05	0.000314	CcSEcCtD
Mercaptopurine—Arthralgia—Epirubicin—breast cancer	5.16e-05	0.000313	CcSEcCtD
Mercaptopurine—Nausea—Paclitaxel—breast cancer	5.13e-05	0.000312	CcSEcCtD
Mercaptopurine—Skin disorder—Methotrexate—breast cancer	5.13e-05	0.000312	CcSEcCtD
Mercaptopurine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	5.12e-05	0.000311	CcSEcCtD
Mercaptopurine—Anorexia—Methotrexate—breast cancer	5.03e-05	0.000306	CcSEcCtD
Mercaptopurine—Leukopenia—Doxorubicin—breast cancer	5.02e-05	0.000305	CcSEcCtD
Mercaptopurine—Diarrhoea—Docetaxel—breast cancer	5.01e-05	0.000305	CcSEcCtD
Mercaptopurine—Oedema—Epirubicin—breast cancer	4.94e-05	0.0003	CcSEcCtD
Mercaptopurine—Diarrhoea—Capecitabine—breast cancer	4.85e-05	0.000295	CcSEcCtD
Mercaptopurine—Thrombocytopenia—Epirubicin—breast cancer	4.84e-05	0.000294	CcSEcCtD
Mercaptopurine—Musculoskeletal discomfort—Methotrexate—breast cancer	4.81e-05	0.000292	CcSEcCtD
Mercaptopurine—Skin disorder—Epirubicin—breast cancer	4.8e-05	0.000292	CcSEcCtD
Mercaptopurine—Arthralgia—Doxorubicin—breast cancer	4.77e-05	0.00029	CcSEcCtD
Mercaptopurine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	4.74e-05	0.000288	CcSEcCtD
Mercaptopurine—Anorexia—Epirubicin—breast cancer	4.71e-05	0.000286	CcSEcCtD
Mercaptopurine—Vomiting—Docetaxel—breast cancer	4.66e-05	0.000283	CcSEcCtD
Mercaptopurine—Rash—Docetaxel—breast cancer	4.62e-05	0.000281	CcSEcCtD
Mercaptopurine—Dermatitis—Docetaxel—breast cancer	4.62e-05	0.00028	CcSEcCtD
Mercaptopurine—Decreased appetite—Methotrexate—breast cancer	4.59e-05	0.000279	CcSEcCtD
Mercaptopurine—Oedema—Doxorubicin—breast cancer	4.57e-05	0.000278	CcSEcCtD
Mercaptopurine—Gastrointestinal disorder—Methotrexate—breast cancer	4.56e-05	0.000277	CcSEcCtD
Mercaptopurine—Vomiting—Capecitabine—breast cancer	4.51e-05	0.000274	CcSEcCtD
Mercaptopurine—Musculoskeletal discomfort—Epirubicin—breast cancer	4.5e-05	0.000274	CcSEcCtD
Mercaptopurine—Thrombocytopenia—Doxorubicin—breast cancer	4.48e-05	0.000272	CcSEcCtD
Mercaptopurine—Rash—Capecitabine—breast cancer	4.47e-05	0.000272	CcSEcCtD
Mercaptopurine—Dermatitis—Capecitabine—breast cancer	4.47e-05	0.000271	CcSEcCtD
Mercaptopurine—Skin disorder—Doxorubicin—breast cancer	4.44e-05	0.00027	CcSEcCtD
Mercaptopurine—Anorexia—Doxorubicin—breast cancer	4.36e-05	0.000265	CcSEcCtD
Mercaptopurine—Nausea—Docetaxel—breast cancer	4.35e-05	0.000264	CcSEcCtD
Mercaptopurine—Decreased appetite—Epirubicin—breast cancer	4.3e-05	0.000261	CcSEcCtD
Mercaptopurine—Gastrointestinal disorder—Epirubicin—breast cancer	4.27e-05	0.000259	CcSEcCtD
Mercaptopurine—Nausea—Capecitabine—breast cancer	4.21e-05	0.000256	CcSEcCtD
Mercaptopurine—Body temperature increased—Methotrexate—breast cancer	4.17e-05	0.000254	CcSEcCtD
Mercaptopurine—Musculoskeletal discomfort—Doxorubicin—breast cancer	4.17e-05	0.000253	CcSEcCtD
Mercaptopurine—Decreased appetite—Doxorubicin—breast cancer	3.98e-05	0.000242	CcSEcCtD
Mercaptopurine—Gastrointestinal disorder—Doxorubicin—breast cancer	3.95e-05	0.00024	CcSEcCtD
Mercaptopurine—Body temperature increased—Epirubicin—breast cancer	3.91e-05	0.000237	CcSEcCtD
Mercaptopurine—Hypersensitivity—Methotrexate—breast cancer	3.89e-05	0.000236	CcSEcCtD
Mercaptopurine—Hypersensitivity—Epirubicin—breast cancer	3.64e-05	0.000221	CcSEcCtD
Mercaptopurine—Body temperature increased—Doxorubicin—breast cancer	3.62e-05	0.00022	CcSEcCtD
Mercaptopurine—Diarrhoea—Methotrexate—breast cancer	3.61e-05	0.00022	CcSEcCtD
Mercaptopurine—Diarrhoea—Epirubicin—breast cancer	3.38e-05	0.000205	CcSEcCtD
Mercaptopurine—Hypersensitivity—Doxorubicin—breast cancer	3.37e-05	0.000205	CcSEcCtD
Mercaptopurine—Vomiting—Methotrexate—breast cancer	3.36e-05	0.000204	CcSEcCtD
Mercaptopurine—Rash—Methotrexate—breast cancer	3.33e-05	0.000202	CcSEcCtD
Mercaptopurine—Dermatitis—Methotrexate—breast cancer	3.33e-05	0.000202	CcSEcCtD
Mercaptopurine—Vomiting—Epirubicin—breast cancer	3.14e-05	0.000191	CcSEcCtD
Mercaptopurine—Nausea—Methotrexate—breast cancer	3.14e-05	0.000191	CcSEcCtD
Mercaptopurine—Diarrhoea—Doxorubicin—breast cancer	3.13e-05	0.00019	CcSEcCtD
Mercaptopurine—Rash—Epirubicin—breast cancer	3.12e-05	0.000189	CcSEcCtD
Mercaptopurine—Dermatitis—Epirubicin—breast cancer	3.11e-05	0.000189	CcSEcCtD
Mercaptopurine—Nausea—Epirubicin—breast cancer	2.94e-05	0.000178	CcSEcCtD
Mercaptopurine—Vomiting—Doxorubicin—breast cancer	2.91e-05	0.000177	CcSEcCtD
Mercaptopurine—Rash—Doxorubicin—breast cancer	2.88e-05	0.000175	CcSEcCtD
Mercaptopurine—Dermatitis—Doxorubicin—breast cancer	2.88e-05	0.000175	CcSEcCtD
Mercaptopurine—Nausea—Doxorubicin—breast cancer	2.72e-05	0.000165	CcSEcCtD
Mercaptopurine—AOX1—Disease—ERBB4—breast cancer	1.02e-05	7.2e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—PRL—breast cancer	1.02e-05	7.2e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—STAT5A—breast cancer	1.02e-05	7.2e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—NCOA2—breast cancer	1.01e-05	7.16e-05	CbGpPWpGaD
Mercaptopurine—XDH—Metabolism—SLC5A5—breast cancer	1.01e-05	7.12e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—ADAM10—breast cancer	1e-05	7.1e-05	CbGpPWpGaD
Mercaptopurine—TPMT—Metabolism—CAV1—breast cancer	1e-05	7.09e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Metabolism—CYP1B1—breast cancer	1e-05	7.09e-05	CbGpPWpGaD
Mercaptopurine—ABCC4—Hemostasis—CAV1—breast cancer	9.96e-06	7.04e-05	CbGpPWpGaD
Mercaptopurine—ABCC4—Platelet activation, signaling and aggregation—MAPK3—breast cancer	9.96e-06	7.04e-05	CbGpPWpGaD
Mercaptopurine—PPAT—Metabolism—PIK3CB—breast cancer	9.94e-06	7.03e-05	CbGpPWpGaD
Mercaptopurine—HPRT1—Metabolism—PIK3CB—breast cancer	9.94e-06	7.03e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—SMAD4—breast cancer	9.87e-06	6.98e-05	CbGpPWpGaD
Mercaptopurine—HPRT1—Metabolism—PTGS2—breast cancer	9.85e-06	6.96e-05	CbGpPWpGaD
Mercaptopurine—PPAT—Metabolism—PTGS2—breast cancer	9.85e-06	6.96e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Metabolism—HSP90AA1—breast cancer	9.84e-06	6.96e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Transmembrane transport of small molecules—ALB—breast cancer	9.84e-06	6.95e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—FASN—breast cancer	9.82e-06	6.94e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—BCHE—breast cancer	9.78e-06	6.91e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—FGF10—breast cancer	9.77e-06	6.91e-05	CbGpPWpGaD
Mercaptopurine—XDH—Metabolism—NQO1—breast cancer	9.73e-06	6.88e-05	CbGpPWpGaD
Mercaptopurine—XDH—Metabolism—SLC2A1—breast cancer	9.73e-06	6.88e-05	CbGpPWpGaD
Mercaptopurine—ABCC4—Platelet activation, signaling and aggregation—TGFB1—breast cancer	9.66e-06	6.83e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—SLC5A5—breast cancer	9.66e-06	6.83e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—HES1—breast cancer	9.63e-06	6.81e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—NCOR1—breast cancer	9.58e-06	6.77e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Metabolism—NCOA1—breast cancer	9.57e-06	6.77e-05	CbGpPWpGaD
Mercaptopurine—XDH—Metabolism—CYP3A4—breast cancer	9.49e-06	6.71e-05	CbGpPWpGaD
Mercaptopurine—ABCC4—Hemostasis—FN1—breast cancer	9.48e-06	6.71e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—FGF1—breast cancer	9.47e-06	6.7e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Metabolism—STK11—breast cancer	9.43e-06	6.67e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Metabolism—CYP19A1—breast cancer	9.43e-06	6.67e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—PDGFA—breast cancer	9.42e-06	6.66e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—NRG1—breast cancer	9.4e-06	6.65e-05	CbGpPWpGaD
Mercaptopurine—ABCC4—Hemostasis—NOS2—breast cancer	9.37e-06	6.63e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—H2AFX—breast cancer	9.33e-06	6.6e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—NQO1—breast cancer	9.33e-06	6.6e-05	CbGpPWpGaD
Mercaptopurine—XDH—Metabolism—CYP1B1—breast cancer	9.33e-06	6.6e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—SLC2A1—breast cancer	9.33e-06	6.6e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—TGFBR2—breast cancer	9.29e-06	6.57e-05	CbGpPWpGaD
Mercaptopurine—XDH—Metabolism—HSP90AA1—breast cancer	9.15e-06	6.47e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—ITPR1—breast cancer	9.14e-06	6.46e-05	CbGpPWpGaD
Mercaptopurine—TPMT—Metabolism—PIK3CG—breast cancer	9.14e-06	6.46e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—CYP3A4—breast cancer	9.1e-06	6.43e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—ERBB4—breast cancer	9.08e-06	6.42e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—STAT5A—breast cancer	9.08e-06	6.42e-05	CbGpPWpGaD
Mercaptopurine—ABCC4—Hemostasis—PIK3CG—breast cancer	9.08e-06	6.42e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—ERCC2—breast cancer	9.01e-06	6.37e-05	CbGpPWpGaD
Mercaptopurine—ABCC4—Hemostasis—EGF—breast cancer	8.97e-06	6.34e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—CYP1B1—breast cancer	8.94e-06	6.32e-05	CbGpPWpGaD
Mercaptopurine—XDH—Metabolism—NCOA1—breast cancer	8.9e-06	6.29e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Transmembrane transport of small molecules—RAF1—breast cancer	8.9e-06	6.29e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—ERBB3—breast cancer	8.81e-06	6.23e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—SMAD4—breast cancer	8.79e-06	6.22e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—FGFR2—breast cancer	8.79e-06	6.22e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—HSP90AA1—breast cancer	8.77e-06	6.2e-05	CbGpPWpGaD
Mercaptopurine—XDH—Metabolism—STK11—breast cancer	8.77e-06	6.2e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Metabolism—COMT—breast cancer	8.77e-06	6.2e-05	CbGpPWpGaD
Mercaptopurine—XDH—Metabolism—CYP19A1—breast cancer	8.77e-06	6.2e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Metabolism—GSTP1—breast cancer	8.73e-06	6.17e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Metabolism—HMOX1—breast cancer	8.61e-06	6.09e-05	CbGpPWpGaD
Mercaptopurine—HPRT1—Metabolism—PTEN—breast cancer	8.59e-06	6.07e-05	CbGpPWpGaD
Mercaptopurine—PPAT—Metabolism—PTEN—breast cancer	8.59e-06	6.07e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Metabolism—ITPR1—breast cancer	8.59e-06	6.07e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—HES1—breast cancer	8.59e-06	6.07e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—NCOR1—breast cancer	8.54e-06	6.04e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—NCOA1—breast cancer	8.53e-06	6.03e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—MTHFR—breast cancer	8.46e-06	5.98e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—TERT—breast cancer	8.44e-06	5.97e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—FGF1—breast cancer	8.44e-06	5.97e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—STK11—breast cancer	8.41e-06	5.94e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—CYP19A1—breast cancer	8.41e-06	5.94e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—NRG1—breast cancer	8.38e-06	5.92e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—H2AFX—breast cancer	8.32e-06	5.88e-05	CbGpPWpGaD
Mercaptopurine—ABCC4—Hemostasis—IGF1—breast cancer	8.31e-06	5.88e-05	CbGpPWpGaD
Mercaptopurine—ABCC4—Hemostasis—AKT2—breast cancer	8.3e-06	5.87e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Metabolism—ABCB1—breast cancer	8.26e-06	5.84e-05	CbGpPWpGaD
Mercaptopurine—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—breast cancer	8.22e-06	5.81e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—FGFR1—breast cancer	8.2e-06	5.79e-05	CbGpPWpGaD
Mercaptopurine—XDH—Metabolism—COMT—breast cancer	8.15e-06	5.76e-05	CbGpPWpGaD
Mercaptopurine—XDH—Metabolism—GSTP1—breast cancer	8.11e-06	5.74e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Metabolism—TYMS—breast cancer	8.11e-06	5.74e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—HIF1A—breast cancer	8.07e-06	5.71e-05	CbGpPWpGaD
Mercaptopurine—TPMT—Metabolism—PIK3CD—breast cancer	8.03e-06	5.68e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—ERCC2—breast cancer	8.03e-06	5.67e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Metabolism—PLA2G4A—breast cancer	8.02e-06	5.67e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Metabolism—NCOR1—breast cancer	8.02e-06	5.67e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Metabolism—GSTM1—breast cancer	8.02e-06	5.67e-05	CbGpPWpGaD
Mercaptopurine—XDH—Metabolism—HMOX1—breast cancer	8e-06	5.66e-05	CbGpPWpGaD
Mercaptopurine—XDH—Metabolism—ITPR1—breast cancer	7.98e-06	5.65e-05	CbGpPWpGaD
Mercaptopurine—ABCC4—Hemostasis—PIK3CD—breast cancer	7.98e-06	5.64e-05	CbGpPWpGaD
Mercaptopurine—TPMT—Metabolism—ALB—breast cancer	7.93e-06	5.61e-05	CbGpPWpGaD
Mercaptopurine—ABCC4—Hemostasis—SERPINE1—breast cancer	7.89e-06	5.58e-05	CbGpPWpGaD
Mercaptopurine—ABCC4—Hemostasis—ALB—breast cancer	7.88e-06	5.57e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—ERBB3—breast cancer	7.85e-06	5.55e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—FGFR2—breast cancer	7.84e-06	5.54e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—COMT—breast cancer	7.82e-06	5.53e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—CAV1—breast cancer	7.81e-06	5.52e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—GSTP1—breast cancer	7.78e-06	5.5e-05	CbGpPWpGaD
Mercaptopurine—XDH—Metabolism—ABCB1—breast cancer	7.68e-06	5.43e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Metabolism—GPX1—breast cancer	7.68e-06	5.43e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—HMOX1—breast cancer	7.67e-06	5.42e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—ITPR1—breast cancer	7.66e-06	5.41e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Metabolism—CYP1A1—breast cancer	7.6e-06	5.38e-05	CbGpPWpGaD
Mercaptopurine—TPMT—Metabolism—NOS3—breast cancer	7.59e-06	5.36e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—MTHFR—breast cancer	7.54e-06	5.33e-05	CbGpPWpGaD
Mercaptopurine—XDH—Metabolism—TYMS—breast cancer	7.54e-06	5.33e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Metabolism—ERCC2—breast cancer	7.54e-06	5.33e-05	CbGpPWpGaD
Mercaptopurine—ABCC4—Hemostasis—NOS3—breast cancer	7.53e-06	5.33e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—TERT—breast cancer	7.52e-06	5.32e-05	CbGpPWpGaD
Mercaptopurine—XDH—Metabolism—PLA2G4A—breast cancer	7.46e-06	5.27e-05	CbGpPWpGaD
Mercaptopurine—XDH—Metabolism—GSTM1—breast cancer	7.46e-06	5.27e-05	CbGpPWpGaD
Mercaptopurine—XDH—Metabolism—NCOR1—breast cancer	7.46e-06	5.27e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—ABCB1—breast cancer	7.36e-06	5.21e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—NOS2—breast cancer	7.34e-06	5.19e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—FGFR1—breast cancer	7.31e-06	5.16e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—NOTCH1—breast cancer	7.27e-06	5.14e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—TYMS—breast cancer	7.23e-06	5.11e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—HIF1A—breast cancer	7.2e-06	5.09e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—PLA2G4A—breast cancer	7.15e-06	5.05e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—GSTM1—breast cancer	7.15e-06	5.05e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—NCOR1—breast cancer	7.15e-06	5.05e-05	CbGpPWpGaD
Mercaptopurine—XDH—Metabolism—GPX1—breast cancer	7.14e-06	5.05e-05	CbGpPWpGaD
Mercaptopurine—ABCC4—Hemostasis—RAF1—breast cancer	7.12e-06	5.04e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—KIT—breast cancer	7.11e-06	5.03e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—APC—breast cancer	7.11e-06	5.03e-05	CbGpPWpGaD
Mercaptopurine—SLC22A8—Transmembrane transport of small molecules—ALB—breast cancer	7.11e-06	5.03e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Metabolism—MTHFR—breast cancer	7.09e-06	5.01e-05	CbGpPWpGaD
Mercaptopurine—XDH—Metabolism—CYP1A1—breast cancer	7.07e-06	5e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—EGF—breast cancer	7.03e-06	4.97e-05	CbGpPWpGaD
Mercaptopurine—XDH—Metabolism—ERCC2—breast cancer	7.01e-06	4.96e-05	CbGpPWpGaD
Mercaptopurine—TPMT—Metabolism—PIK3CB—breast cancer	7e-06	4.95e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—CAV1—breast cancer	6.96e-06	4.92e-05	CbGpPWpGaD
Mercaptopurine—ABCC4—Hemostasis—PIK3CB—breast cancer	6.95e-06	4.92e-05	CbGpPWpGaD
Mercaptopurine—TPMT—Metabolism—PTGS2—breast cancer	6.94e-06	4.91e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—GPX1—breast cancer	6.85e-06	4.84e-05	CbGpPWpGaD
Mercaptopurine—ABCC4—Transmembrane transport of small molecules—ALB—breast cancer	6.82e-06	4.82e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—CYP1A1—breast cancer	6.78e-06	4.79e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—ERCC2—breast cancer	6.72e-06	4.75e-05	CbGpPWpGaD
Mercaptopurine—ABCC4—Platelet activation, signaling and aggregation—AKT1—breast cancer	6.72e-06	4.75e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—BRAF—breast cancer	6.68e-06	4.73e-05	CbGpPWpGaD
Mercaptopurine—XDH—Metabolism—MTHFR—breast cancer	6.59e-06	4.66e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—NOS2—breast cancer	6.55e-06	4.63e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Metabolism—CAV1—breast cancer	6.54e-06	4.62e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—AKT2—breast cancer	6.51e-06	4.6e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—NOTCH1—breast cancer	6.48e-06	4.58e-05	CbGpPWpGaD
Mercaptopurine—SLC22A8—Transmembrane transport of small molecules—RAF1—breast cancer	6.43e-06	4.55e-05	CbGpPWpGaD
Mercaptopurine—ABCC4—Hemostasis—IL2—breast cancer	6.39e-06	4.52e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—KIT—breast cancer	6.34e-06	4.48e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—APC—breast cancer	6.34e-06	4.48e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—MTHFR—breast cancer	6.32e-06	4.47e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—EGF—breast cancer	6.27e-06	4.43e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—PIK3CD—breast cancer	6.25e-06	4.42e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—SERPINE1—breast cancer	6.18e-06	4.37e-05	CbGpPWpGaD
Mercaptopurine—ABCC4—Transmembrane transport of small molecules—RAF1—breast cancer	6.17e-06	4.36e-05	CbGpPWpGaD
Mercaptopurine—XDH—Metabolism—CAV1—breast cancer	6.08e-06	4.3e-05	CbGpPWpGaD
Mercaptopurine—HPRT1—Metabolism—PIK3CA—breast cancer	6.06e-06	4.28e-05	CbGpPWpGaD
Mercaptopurine—PPAT—Metabolism—PIK3CA—breast cancer	6.06e-06	4.28e-05	CbGpPWpGaD
Mercaptopurine—TPMT—Metabolism—PTEN—breast cancer	6.05e-06	4.28e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—BRAF—breast cancer	5.96e-06	4.21e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Metabolism—PIK3CG—breast cancer	5.96e-06	4.21e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—NOS3—breast cancer	5.9e-06	4.17e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—CAV1—breast cancer	5.83e-06	4.12e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—AKT2—breast cancer	5.8e-06	4.1e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—MDM2—breast cancer	5.6e-06	3.96e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—RAF1—breast cancer	5.58e-06	3.95e-05	CbGpPWpGaD
Mercaptopurine—ABCC4—Hemostasis—SRC—breast cancer	5.57e-06	3.94e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—PIK3CD—breast cancer	5.57e-06	3.94e-05	CbGpPWpGaD
Mercaptopurine—XDH—Metabolism—PIK3CG—breast cancer	5.54e-06	3.91e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—ERBB2—breast cancer	5.52e-06	3.9e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—SERPINE1—breast cancer	5.51e-06	3.9e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—MTOR—breast cancer	5.45e-06	3.85e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—PIK3CB—breast cancer	5.45e-06	3.85e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—CD4—breast cancer	5.44e-06	3.85e-05	CbGpPWpGaD
Mercaptopurine—ABCC4—Hemostasis—VEGFA—breast cancer	5.43e-06	3.84e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—PTGS2—breast cancer	5.4e-06	3.82e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—PIK3CG—breast cancer	5.31e-06	3.75e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—NOS3—breast cancer	5.26e-06	3.72e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Metabolism—PIK3CD—breast cancer	5.24e-06	3.7e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Metabolism—ALB—breast cancer	5.17e-06	3.65e-05	CbGpPWpGaD
Mercaptopurine—ABCC4—Hemostasis—MAPK3—breast cancer	5.13e-06	3.63e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—CDKN1B—breast cancer	5.11e-06	3.62e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—MDM2—breast cancer	4.99e-06	3.53e-05	CbGpPWpGaD
Mercaptopurine—ABCC4—Hemostasis—TGFB1—breast cancer	4.98e-06	3.52e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—RAF1—breast cancer	4.97e-06	3.52e-05	CbGpPWpGaD
Mercaptopurine—HPRT1—Metabolism—AKT1—breast cancer	4.95e-06	3.5e-05	CbGpPWpGaD
Mercaptopurine—PPAT—Metabolism—AKT1—breast cancer	4.95e-06	3.5e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Metabolism—NOS3—breast cancer	4.94e-06	3.5e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—ERBB2—breast cancer	4.92e-06	3.48e-05	CbGpPWpGaD
Mercaptopurine—XDH—Metabolism—PIK3CD—breast cancer	4.87e-06	3.44e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—MTOR—breast cancer	4.86e-06	3.43e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—PIK3CB—breast cancer	4.86e-06	3.43e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—CD4—breast cancer	4.85e-06	3.43e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—CTNNB1—breast cancer	4.83e-06	3.42e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—PTGS2—breast cancer	4.81e-06	3.4e-05	CbGpPWpGaD
Mercaptopurine—XDH—Metabolism—ALB—breast cancer	4.81e-06	3.4e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—CDKN1A—breast cancer	4.72e-06	3.34e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—PTEN—breast cancer	4.71e-06	3.33e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—PIK3CD—breast cancer	4.67e-06	3.3e-05	CbGpPWpGaD
Mercaptopurine—ABCC4—Hemostasis—KRAS—breast cancer	4.61e-06	3.26e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—ALB—breast cancer	4.61e-06	3.26e-05	CbGpPWpGaD
Mercaptopurine—XDH—Metabolism—NOS3—breast cancer	4.6e-06	3.25e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Metabolism—PIK3CB—breast cancer	4.56e-06	3.23e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—CDKN1B—breast cancer	4.56e-06	3.22e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Metabolism—PTGS2—breast cancer	4.52e-06	3.2e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—NOS3—breast cancer	4.41e-06	3.12e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—SRC—breast cancer	4.37e-06	3.09e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—CTNNB1—breast cancer	4.31e-06	3.04e-05	CbGpPWpGaD
Mercaptopurine—TPMT—Metabolism—PIK3CA—breast cancer	4.27e-06	3.02e-05	CbGpPWpGaD
Mercaptopurine—XDH—Metabolism—PIK3CB—breast cancer	4.24e-06	3e-05	CbGpPWpGaD
Mercaptopurine—ABCC4—Hemostasis—PIK3CA—breast cancer	4.24e-06	3e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—STAT3—breast cancer	4.21e-06	2.98e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—CDKN1A—breast cancer	4.21e-06	2.97e-05	CbGpPWpGaD
Mercaptopurine—XDH—Metabolism—PTGS2—breast cancer	4.2e-06	2.97e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—PTEN—breast cancer	4.2e-06	2.97e-05	CbGpPWpGaD
Mercaptopurine—ABCC4—Hemostasis—TP53—breast cancer	4.1e-06	2.9e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—PIK3CB—breast cancer	4.07e-06	2.88e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—PTGS2—breast cancer	4.03e-06	2.85e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—MAPK3—breast cancer	4.02e-06	2.84e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Metabolism—PTEN—breast cancer	3.94e-06	2.79e-05	CbGpPWpGaD
Mercaptopurine—ABCC4—Hemostasis—HRAS—breast cancer	3.92e-06	2.77e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—MYC—breast cancer	3.91e-06	2.77e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—TGFB1—breast cancer	3.9e-06	2.76e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—SRC—breast cancer	3.89e-06	2.75e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—EGFR—breast cancer	3.83e-06	2.71e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—STAT3—breast cancer	3.75e-06	2.65e-05	CbGpPWpGaD
Mercaptopurine—XDH—Metabolism—PTEN—breast cancer	3.67e-06	2.59e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—KRAS—breast cancer	3.62e-06	2.56e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—MAPK3—breast cancer	3.59e-06	2.54e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—PTEN—breast cancer	3.51e-06	2.49e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—MYC—breast cancer	3.49e-06	2.47e-05	CbGpPWpGaD
Mercaptopurine—TPMT—Metabolism—AKT1—breast cancer	3.49e-06	2.47e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—TGFB1—breast cancer	3.48e-06	2.46e-05	CbGpPWpGaD
Mercaptopurine—ABCC4—Hemostasis—AKT1—breast cancer	3.46e-06	2.45e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—EGFR—breast cancer	3.41e-06	2.41e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—PIK3CA—breast cancer	3.32e-06	2.35e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—KRAS—breast cancer	3.22e-06	2.28e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—HRAS—breast cancer	3.07e-06	2.17e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—PIK3CA—breast cancer	2.96e-06	2.09e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—IL6—breast cancer	2.94e-06	2.08e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Metabolism—PIK3CA—breast cancer	2.78e-06	1.97e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—HRAS—breast cancer	2.74e-06	1.94e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—AKT1—breast cancer	2.71e-06	1.92e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—IL6—breast cancer	2.62e-06	1.85e-05	CbGpPWpGaD
Mercaptopurine—XDH—Metabolism—PIK3CA—breast cancer	2.59e-06	1.83e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—PIK3CA—breast cancer	2.48e-06	1.75e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—AKT1—breast cancer	2.42e-06	1.71e-05	CbGpPWpGaD
Mercaptopurine—AOX1—Metabolism—AKT1—breast cancer	2.27e-06	1.61e-05	CbGpPWpGaD
Mercaptopurine—XDH—Metabolism—AKT1—breast cancer	2.11e-06	1.49e-05	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—AKT1—breast cancer	2.03e-06	1.43e-05	CbGpPWpGaD
